Advertisement

Topics

Terumo Heart Inc. Company Profile

00:07 EDT 23rd October 2017 | BioPortfolio

More than 22 million people suffer from heart failure worldwide with approximately one million new patients diagnosed annually. In the setting of an aging global population, heart failure is the number one reason for hospitalization. The most severely ill patients need heart transplants in order to recover. More than 8,000 people worldwide are on the list of eligible candidates for heart transplants annually, but less than 4,000 will receive a transplant each year. A large number of people who suffer from severe heart failure do not qualify for transplantation due to other health issues. An alternative for these patients is access to artificial mechanical assist devices. Left Ventricular Assist Systems (LVAS) are a type of mechanical circulatory device specifically designed to improve the lives of patients waiting for donor hearts, as well as those who are ineligible for a heart transplant.


News Articles [1118 Associated News Articles listed on BioPortfolio]

Sven Lee: How Terumo BCT are unlocking the potential of blood.

Terumo BCT, is the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction coupled with leading technologies in therapeut...

Getting to the heart of the matter: Nanogels for heart attack patients

Heart disease and heart-related illnesses are a leading cause of death around the world, but treatment options are limited. Now, one group reports in ACS Nano that encapsulating stem cells in a nanoge...

Biology of mending a broken heart

Scientists might be on to a way to preserve heart function after heart attacks or for people with inherited heart defects called congenital cardiomyopathies. Researchers report that after simulating h...

Patching up a broken heart

It is almost impossible for an injured heart to fully mend itself. Within minutes of being deprived of oxygen – as happens during a heart attack when arteries to the heart are blocked – the heart'...

Global Artificial Heart Lung Machines Market Data Survey Report 2025 [Report Updated: 02092017] Prices from USD $1500

SummaryArtificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heartlung machine is often referred to as...

ivWatch Teams with Terumo for Distribution

ivWatch, a medical device company working for continuous IV infiltration and extravasation detection technology will now be distributed! Terumo Corporation, international medical device manufacturers ...

Terumo Corporation Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 11062017] Prices from USD $350

Terumo Corporation Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Terumo Corporation Mergers Acquisitions MA, Partnerships Alliances and Investments repo...

Terumo gains exclusive rights to sell Cohera's Sylys sealant in Japan

Cohera Medical Inc. granted Terumo Corp. exclusive rights to sell its Sylys surgical sealant in Japan.

PubMed Articles [2052 Associated PubMed Articles listed on BioPortfolio]

Contemporary Approaches to Patients with Heart Failure.

Incident heart failure and the burden of hospitalization may be demonstrating a decline. However, as the population ages, the prevalence of heart failure continues to increase. Mortality among heart f...

Berlin Heart EXCOR use in patients with congenital heart disease.

Management of mechanical circulatory support in children with congenital heart disease (CHD) is challenging due to physiologic variations and anatomic limitations to device placement. In this study we...

Heart Rate, Heart Rhythm, and Prognostic Benefits of Beta-Blockers in Heart Failure: Individual Patient-Data Meta-Analysis.

The relationship between mortality and heart rate remains unclear for patients with heart failure and reduced ejection fraction (HFrEF) in either sinus rhythm or atrial fibrillation (AF).

Corrigendum to: Sacubitril/valsartan and low blood pressure in heart failure with reduced ejection fraction Eur Heart J 2017; doi:10.1093/eurheartj/ehx014.

Announcement: American Heart Month - February 2017.

Each February, the observance of American Heart Month helps raise awareness of ways to stay heart healthy and prevent heart disease. For 30 years, the number of deaths from heart disease, the number o...

Clinical Trials [3288 Associated Clinical Trials listed on BioPortfolio]

Prospective, Randomized Controlled Comparison of TERUMO SurFlash Plus Versus BD Insyte Autoguard in an Urban ED

A randomized prospective comparison of two FDA approved intravenous catheters in the emergency department setting. The Terumo SurFlash Plus offers novel technologies that promise to increa...

Comparison of Two Automated Mononuclear Collection Systems in Patients Undergoing Extracorporeal Photochemotherapy. A Cross-over Equivalence Study. (MNC_CMNC)

In a study performed in 2012, the investigators demonstrated that in ECP setting , the new automated device (Spectra Optia-MNC) released by Terumo BCT for MNCs collection based on intermi...

Radial Artery Patency and Bleeding, Efficacy, Adverse evenT Trial

The objectives of this study are to demonstrate the safety and efficacy of the new 6Fr sheath (Glidesheath slender; Terumo, Tokyo,Japan ; GSS) compared with the contemporary 5Fr sheath (Hy...

Intradermal Rabies Immunization Using NanoJect: A Comparative Study

The study is planned as a single-center, randomized, double-blind placebo-controlled, comparative Phase I, first-in-man study to assess the safety and tolerability of the NanoJect™ devic...

Study of Access Site for Enhancing PCI in STEMI for Seniors (SAFE STEMI for Seniors)

Patients with partially blocked blood vessel(s) in their heart may need a medical procedure called "Percutaneous Coronary Intervention (PCI)" to open the narrowed blood vessel(s). The purp...

Companies [681 Associated Companies listed on BioPortfolio]

Terumo Interventional Systems

Terumo Interventional Systems (TIS), a strategic business unit of Terumo Medical Corporation, directly markets a full line of guidewires, catheters, introducer sheaths, guiding sheaths and embolizatio...

Terumo Heart Inc.

More than 22 million people suffer from heart failure worldwide with approximately one million new patients diagnosed annually. In the setting of an aging global population, heart failure is the numbe...

Terumo Heart, Inc.

Founded 1971 Terumo® Europe NV manufactures, exports, imports, markets and sells a wide range of quality products for angiography, cardiology and cardiovascular systems, transfusion, clinical test sy...

Terumo BCT

Terumo BCT, a global leader in blood component and cellular technologies, is the only company with the unique combination of apheresis collections, manual and automated whole bloo...

MicroVention-Terumo, Inc.

More Information about "Terumo Heart Inc." on BioPortfolio

We have published hundreds of Terumo Heart Inc. news stories on BioPortfolio along with dozens of Terumo Heart Inc. Clinical Trials and PubMed Articles about Terumo Heart Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Terumo Heart Inc. Companies in our database. You can also find out about relevant Terumo Heart Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...


Corporate Database Quicklinks



Searches Linking to this Company Record